Why the study?
Are there age and gender differences in medical adherence to secondary prevention therapies one year after myocardial infarction?
Are there age and gender differences in medical adherence to secondary prevention therapies one year after myocardial infarction?
This nationwide study highlights significant gaps in secondary prevention medication adherence after myocardial infarction, particularly among women, younger, and older patients, and those with NSTEMI.
Answers are grounded in this paper and cite their sources.
Adherence gaps in NSTEMI and women may guide targeted strategies; leaves open causal drivers and outcome effects in observational data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eindhoven et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: